Canatu Plc – Managers’ transactions – Timo Suominen
Canatu Plc Managers’ transactions 17 September 2024 at 3:00 pm EEST
Canatu Plc – Managers’ transactions – Timo Suominen
____________________________________________
Person subject to the notification requirement
Name: Timo Suominen
Position: Chief Financial Officer
Issuer: Canatu Plc
LEI: 743700CKOP7IHGI98B12
Notification type: INITIAL NOTIFICATION
Reference number: 77589/13/16
____________________________________________
Transaction date: 2024-09-16
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: Canatu Plc option right 2024-I
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
Transaction details
(1): Volume: 86461 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 86461 Volume weighted average price: 0 EUR
____________________________________________
Transaction date: 2024-09-16
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: Canatu Plc option right 2024-II
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
Transaction details
(1): Volume: 25788 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 25788 Volume weighted average price: 0 EUR
Additional information
Juha Kokkonen
CEO
tel. +358 40 543 0367
Certified adviser
Carnegie Investment Bank AB (publ)
tel. +46 (0)73 856 42 65
About Canatu
Canatu (CANATU, Nasdaq First North, Finland) is a fast-growing deep technology company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.
Canatu’s versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling the manufacturing of the most advanced chips, as well as film heaters for advanced driver-assistance systems (ADAS) in the automotive industry. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and Dry DepositionTM method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.
Headquartered in Finland, Canatu also operates in the US, Japan, and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has around 130 employees representing over 30 nationalities, with 20 percent holding or pursuing doctorates. Discover more at www.canatu.com and follow us on LinkedIn.
